Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for Patent: 7,498,311

« Back to Dashboard
Patent 7,498,311 protects TOPAMAX and TOPAMAX SPRINKLE and is included in two NDAs. There have been zero Paragraph IV challenges on Topamax and Topamax Sprinkle

Protection for TOPAMAX has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.

Summary for Patent: 7,498,311

Title:Treatment of migraine
Abstract:A method for treating migraine in non-epileptic subjects which involves administering to subjects an effective amount of a pharmaceutical composition comprising a sulfamate of the following formula: ##STR00001##
Inventor(s): Ehrenberg; Bruce L. (Boston, MA), Wagner; Anita K. (Cambridge, MA)
Assignee: New England Medical Center Hospitals, Inc. (Boston, MA)
Application Number:11/326,783
Patent Claim Types:
see list of patent claims
Use; Delivery; Composition;
Patent Metrics:
Source: PatentQuant.com
Field: Pharmaceuticals
Back Citations: 8th percentile
Forward Citations: 0th percentile

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Janssen Pharms
TABLET;ORAL020505-004Dec 24, 1996RXNo7,498,311*PEDApr 13, 2016Y
Janssen Pharms
TABLET;ORAL020505-005Dec 24, 1996RXNo7,498,311*PEDApr 13, 2016Y
Janssen Pharms
TABLET;ORAL020505-001Dec 24, 1996RXYes7,498,311*PEDApr 13, 2016Y
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.